Specialized in medical prescription products, the Genom business unit acts in several medical areas, offering high quality products in the line of Ophthalmology and General Medicine (Pain/SNC/GO) and Dermatology
Genom Ophthalmology Division occupies the first place among the national laboratories in this segment both in invoicing information (IMS) and also prescription (close-up). With a comprehensive portfolio for treatment of chronic and acute diseases, Genom Ophthalmology reckons on the strong recognition of the medical profession and the medical ophthalmology organization. Partnerships with other national and international companies are part of Genom Ophthalmology Division’s strategy, focusing always on the provision of cutting-edge treatments that can be easily accessed by the Brazilian population.
Genom General Medicine (Pain/SNC/GO) Division enables the population’s access to important medicines for the treatment of problems related to pain and central nervous system. Their portfolio includes antidepressants, painkillers, muscle relaxers, anti-inflammatory medication, among others.
In the line of Gynecology, with the strong tradition in the production of hormones, Genom offers hormonal contraceptives, prenatal multivitamins with minerals, painkillers, antidepressants and anti-inflammatories medication.
Genom began in March 2017 with the mission of developing and promoting products (medicines, nutraceuticals and dermocosmetics) that are daily in the prescriptions of the dermatologist.
Brazilian company with more than 80 years of history in the pharmaceutical market.
Avenida Magalhães de Castro, 4.800
16º andar - Conjuntos 161 e 162
Edifício Continental Tower
05676-120 / São Paulo-SP
Copyright © 2020 União Química. All rights reserved